(PRVL) |
| 0 (0%) 07-16 14:18 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.88 |
| Resistance 1: | 1.77 |
| Pivot price: | 1.69 |
| Support 1: | 1.58 |
| Support 2: | 1.31 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 4193.333 |
| Profit Margin (%) | 73.74 |
| Operating Margin (%) | 94.59 |
| Return on Assets (ttm) | 9.3 |
| Return on Equity (ttm) | 12.3 |
Company news
Mon, 24 Nov 2025
Americans Will Be Able to Buy A Protein Powder Made from Air in 2026 - Green Queen Media
Thu, 20 Nov 2025
Pothos to debut Solein-powered protein powders in the US - Nutrition Insight
Thu, 10 Nov 2022
Asa Abeliovich Net Worth (2026) - GuruFocus
Sun, 18 Jul 2021
Prevail Therapeutics Announces Pricing of Initial Public Offering - IPO Edge
Fri, 22 Jan 2021
Lilly Completes Acquisition of Prevail Therapeutics - Eli Lilly and Company
Fri, 18 Dec 2020
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Prevail Therapeutics, Inc. - PRVL - marketscreener.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
